ENVALITH
富士紡ホールディングス株式会社 logo

Fujibo Holdings, Inc.

3104・Prime Market・Textiles & Apparels

Official website
富士紡ホールディングス株式会社 logo
Fujibo Holdings, Inc.3104

Business

Fujibo Holdings, founded in 1896, is a holding company operating four business segments through 12 subsidiaries. In its core Abrasives Business, the company sells ultra-precision processing abrasives for semiconductor devices (CMP), silicon wafers, hard disks, and LCD glass to IT device-related companies worldwide. In the Chemical Industrial Products Business, the company supplies intermediates for pharmaceuticals, agrochemicals, and electronic materials, centered on contract organic synthesis manufacturing. In the Life & Apparel Business, the company offers innerwear primarily under the B.V.D. brand, while the Other segment covers chemical products, molds, and automotive-related operations. The company is listed on the Prime Market of the Tokyo Stock Exchange.

Business Model

The abrasives business sells in-house developed ultra-precision processing abrasives to IT device manufacturers worldwide, both through direct sales and via trading companies, achieving an operating margin exceeding 28% on the back of high technological barriers to entry. The chemical industrial products business secures stable orders through a contract manufacturing model with major chemical manufacturers. The daily apparel business supplies branded products through an integrated in-group system spanning everything from yarn spinning to garment sewing. Capital expenditure is funded through internal resources, allowing the company to continue growth investment while maintaining financial soundness.

Company Strengths

In the abrasives business for FY2026 (ending March 2026), net sales reached ¥22,561 million, operating income ¥6,385 million, and the operating margin achieved 28.3%. Fujibo Ehime Co., Ltd. and Taiwan Fuji Spinning Precision Materials Co., Ltd. handle manufacturing and sales, and a joint development framework with users has been established, including a technology development building at the Nyugawa Plant and an R&D facility in Taiwan. Order intake stood at ¥24,569 million (up 17.0% year on year), and the order backlog reached ¥5,620 million (up 28.7%), with leading indicators also remaining solid.

The equity ratio for FY2026 (ending March 2026) rose to 72.0%, marking the fourth consecutive year of increase. Interest-bearing debt is at nearly zero level (cash flow to interest-bearing debt ratio of 0.0), and the interest coverage ratio reached 923.2 times. Operating cash flow generated ¥10,143 million, and while capital expenditures of ¥8,081 million were fully funded internally, the cash balance also increased to ¥9,517 million.

Yanai Chemical Industry Co., Ltd. operates one of Japan's leading contract chemical manufacturing plants, handling a wide variety of organic synthesis reactions for pharmaceuticals, agrochemicals, electronic materials, functional chemicals, and more. In FY2026 (ending March 2026), net sales reached ¥14,113 million, and the operating margin improved to 10.0% (up from 9.0% in the previous period). Construction of the fifth plant, scheduled to begin operation in April 2026, was completed, and order intake was also robust at ¥21,100 million (up 21.3% year on year), indicating strong future demand.

ENVALITH's Perspective

In FY2026 (ending March 2026), net sales reached ¥45,929 million (up 7.0% year on year) and operating profit reached ¥8,143 million (up 25.7% year on year), achieving substantial profit growth for the second consecutive period. The abrasives business drove overall performance with net sales of ¥22,561 million (up 16.9% year on year) and operating profit of ¥6,385 million (up 35.0% year on year). The company's forecast for FY2027 (ending March 2027) calls for continued high growth, with net sales of ¥52,700 million (up 14.7% year on year) and operating profit of ¥9,200 million (up 13.0% year on year). As an external factor, the continued expansion of semiconductor investment driven by the spread of generative AI is providing a tailwind, and the company's performance shows high sensitivity to the AI investment cycle.

In its forecast for FY2027 (ending March 2027), the company factors in rising raw material and fuel prices and a lag before these costs can be passed through to selling prices, expecting a decrease in operating profit of approximately 5% in the abrasives business and approximately 10% in the chemical industrial products business. The impact of the situation in the Middle East is also recognized as a downward pressure factor on profit. Trends in U.S. trade policy also represent an uncertainty, and deterioration in the external environment falling short of forecasts is a risk requiring close attention. On the other hand, at present there has been no change in customer demand, and the company states that it has already secured raw materials and fuel for the near term.

The lifestyle apparel business continued to see declining sales and profit, with net sales of ¥6,323 million (down 9.2% year on year) and operating profit of ¥438 million (down 25.3% year on year); although structural reforms such as the discontinuation of production at the Kosakai plant are progressing, they have not yet led to fundamental improvement. The Other segment saw its operating loss widen to ¥98 million. Furthermore, impairment losses for FY2026 (ending March 2026) swelled to ¥778 million (a substantial increase from ¥141 million in the previous period), with ¥600 million recorded in the Other segment and ¥166 million in company-wide eliminations. Improving profitability in non-core businesses and enhancing asset efficiency remain medium- to long-term challenges.

Growth Strategy

Pursuing sustainable growth through strengthening the abrasives and chemical industrial products businesses and structural reform of the daily apparel business

Captured increased demand for CMP abrasives for HBM and leading-edge logic driven by the spread of generative AI, expanding sales to Sumitomo Corporation Chemical Co., Ltd. by 32.3% year-on-year to ¥10,887 million. Demand for HDD applications for data centers and LCD glass applications also recovered, achieving segment revenue of ¥22,561 million and an operating margin of 28.3%. A steady performance trend is also expected in FY2027 (ending March 2027).

Continued capital investment aimed at expanding contract manufacturing of electronic materials and pharmaceutical/agrochemical intermediates (segment capital expenditure of ¥4,432 million in FY2026, ending March 2026). The new plant began operation in April 2026, and increased production capacity and stable operations are expected to expand earnings. Demand recovery following the completion of inventory adjustments in the agrochemical market is also providing a tailwind.

Discontinued production and sales at the Kozakai Plant to concentrate management resources on highly profitable businesses. Deployed an OMO (online-merges-with-offline) strategy combining e-commerce and physical stores for outdoor products, and strengthened wholesale and promotional activities to specialty stores. Efforts continue to secure profit through strengthened e-commerce sales, but the environment remains challenging due to rising personnel costs, the weak yen, and consumer spending restraint.

As the final year of the medium-term management plan 'Zoukyo 21-25,' the company pursued 'reform of the business portfolio' and 'strengthening of each business,' achieving revenue of ¥45,929 million and operating profit of ¥8,143 million in FY2026 (ending March 2026). For FY2027 (ending March 2027), revenue of ¥52,700 million and operating profit of ¥9,200 million are forecast, with efforts underway to build a growth foundation in anticipation of the transition to the next plan.

Last updated: July 19, 2026